Diagnosing ALL

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 180 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Acute Leukemia with a Focus on WHO Classification. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Acute Leukemia with a Focus on WHO Classification (online CE course)
Diagnosing ALL

As with AML, ALL is first suspected when blasts are seen on the peripheral blood smear. 20% or greater blasts in the blood or bone marrow constitute a diagnosis of acute leukemia, and then establishing that they are lymphoblasts will give an initial diagnosis as ALL. Techniques as described in the section on cytochemical stains can help distinguish myeloblasts from lymphoblasts.
In ALL, lymphoblasts can sometimes be very numerous, as much as 90% of the total white blood count. Bone marrow smears and biopsies are usually done next; the bone marrow can typically show between 25-95% lymphoblasts. To further establish a definitive diagnosis, immunophenotyping using flow cytometry and cytogenetic studies can be performed. More information on this will follow under laboratory diagnosis.
Also, a lumbar puncture to analyze the CSF is usually done upon initial diagnosis. If the central nervous system is involved, further testing might be done. Coagulation studies and baseline chemistries are also done.
The image at the right shows a smear with numerous lymphoblasts.
10. Patho. "Bone Marrow: Acute Lymphoblastic Leukemia, L1 (ALL-L1)." Wikimedia Commons, 8 Jul 2008, https://commons.wikimedia.org/wiki/File:ALL-L1.jpg

A smear with numerous lymphoblasts (ALL L1) (10).